These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 20572032)
21. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
22. Central challenges facing the national clinical research enterprise. Sung NS; Crowley WF; Genel M; Salber P; Sandy L; Sherwood LM; Johnson SB; Catanese V; Tilson H; Getz K; Larson EL; Scheinberg D; Reece EA; Slavkin H; Dobs A; Grebb J; Martinez RA; Korn A; Rimoin D JAMA; 2003 Mar; 289(10):1278-87. PubMed ID: 12633190 [TBL] [Abstract][Full Text] [Related]
23. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations. Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590 [TBL] [Abstract][Full Text] [Related]
24. An evidence integration triangle for aligning science with policy and practice. Glasgow RE; Green LW; Taylor MV; Stange KC Am J Prev Med; 2012 Jun; 42(6):646-54. PubMed ID: 22608384 [TBL] [Abstract][Full Text] [Related]
25. Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska. Copur MS; Ramaekers R; Gönen M; Gulzow M; Hadenfeldt R; Fuller C; Scott J; Einspahr S; Benzel H; Mickey M; Norvell M; Clark D; Gauchan D; Kurbegov D; Copur MS; Ramaekers R; Gönen M; Gulzow M; Hadenfeldt R; Fuller C; Scott J; Einspahr S; Benzel H; Mickey M; Norvell M; Clark D; Gauchan D; Kurbegov D J Oncol Pract; 2016 Jan; 12(1):67-8, e44-51. PubMed ID: 26265173 [TBL] [Abstract][Full Text] [Related]
26. Symptom science research conducted in community programs funded by the US National Cancer Institute: a 12-year review, 2008 to 2019. Germain DS; Stevens WM; O'Mara A Support Care Cancer; 2022 Jun; 30(6):4739-4746. PubMed ID: 35122531 [TBL] [Abstract][Full Text] [Related]
27. NCI Cancer Imaging Program efforts and their application to non-conventional radionuclides. Croft BY Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):107-10. PubMed ID: 18043543 [TBL] [Abstract][Full Text] [Related]
28. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation. Carpenter WR; Meyer AM; Wu Y; Qaqish B; Sanoff HK; Goldberg RM; Weiner BJ Med Care; 2012 Aug; 50(8):737-48. PubMed ID: 22437624 [TBL] [Abstract][Full Text] [Related]
29. Linking scientific discovery and better health for the nation: the first three years of the NIH's Clinical and Translational Science Awards. Califf RM; Berglund L; Acad Med; 2010 Mar; 85(3):457-62. PubMed ID: 20182118 [TBL] [Abstract][Full Text] [Related]
31. Challenges and facilitators of community clinical oncology program participation: a qualitative study. McAlearney AS; Reiter KL; Weiner BJ; Minasian L; Song PH J Healthc Manag; 2013; 58(1):29-44; discussion 45-6. PubMed ID: 23424817 [TBL] [Abstract][Full Text] [Related]
32. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders. Brady LS; Winsky L; Goodman W; Oliveri ME; Stover E Neuropsychopharmacology; 2009 Jan; 34(1):229-43. PubMed ID: 18800066 [TBL] [Abstract][Full Text] [Related]
33. Twenty five years of the National Academy of Medical Sciences of Ukraine - progress and priorities for future of radiation medicine and biology. Bazyka D Probl Radiac Med Radiobiol; 2017 Dec; 22():10-14. PubMed ID: 29286493 [TBL] [Abstract][Full Text] [Related]
34. Implementing community-based provider participation in research: an empirical study. Teal R; Bergmire DM; Johnston M; Weiner BJ Implement Sci; 2012 May; 7():41. PubMed ID: 22568935 [TBL] [Abstract][Full Text] [Related]
35. What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report. Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N Cancer; 2020 Dec; 126(23):5022-5029. PubMed ID: 32970346 [TBL] [Abstract][Full Text] [Related]
36. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers. Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975 [TBL] [Abstract][Full Text] [Related]
37. The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets. Shoemaker RH; Suen CS; Holmes CA; Fay JR; Steele VE Semin Oncol; 2016 Feb; 43(1):189-197. PubMed ID: 26970137 [TBL] [Abstract][Full Text] [Related]
38. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987. Frelick RW J Clin Oncol; 1994 Aug; 12(8):1718-23. PubMed ID: 8040683 [TBL] [Abstract][Full Text] [Related]
39. Organizational and physician factors associated with patient enrollment in cancer clinical trials. Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of a partnership approach to translating research on breast cancer and the environment. Van Olphen J; Ottoson J; Green L; Barlow J; Koblick K; Hiatt R Prog Community Health Partnersh; 2009; 3(3):213-26. PubMed ID: 20208222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]